Skip to content
AlternativeMed

NAD, NMN, Resveratrol and Longevity Claims: What Humans Show

A claim check on NAD+, NMN, nicotinamide riboside, resveratrol, senolytics, rapamycin, metformin and biological-age tests, separating animal findings, blood markers and human outcomes.

Content last updated . This page has not been medically reviewed.

The key idea: three different kinds of evidence

Longevity claims often mix up three things:
  1. Preclinical (animal or lab only): something extended the life of mice or changed cells in a dish.
  2. A biomarker in people: a blood level or test result changed, such as NAD+ in the blood.
  3. A human outcome: people lived longer, stayed independent longer, or had fewer falls, fractures or diseases.

A change in a biomarker is not the same as a longer or healthier life. This page keeps the three apart. Evidence labels: established recommendation, promising but limited, mixed, insufficient evidence, preclinical (animal or lab only). For the broader specialty topic, see Longevity.

NIA says ads for supplements sometimes promise to help you live longer, and that there is often little, if any, science supporting these claims. [1]

Claim check

ClaimAnimal / labHuman biomarkerHuman outcome (function, disease, lifespan)
NMN and NR (NAD+ boosters) "restore youth"Authors of a human trial state that in animal studies NMN raises NAD and improves healthspan and lifespan. [2] (preclinical)Blood NAD+ rose in trials of NMN and of nicotinamide riboside. [2] [3]Small short trials with mixed function results; no lifespan or disease-prevention data found (see below).
ResveratrolIn genetically diverse mice, resveratrol did not significantly change survival. [4] (preclinical)A meta-analysis of 17 human studies found improved endothelial function markers. [5]A review said there is a lack of unambiguous information on polyphenols' effectiveness and safety for increasing health span in humans. [6]
Senolytics (clear "zombie" cells)The authors of a human trial state that preclinical evidence shows senolytics delay several age-related conditions. [7] (preclinical)In 9 people with diabetic kidney disease, 3 days of dasatinib plus quercetin reduced senescent cell markers. [8]In 60 postmenopausal women, the primary bone-marker endpoint did not differ from control. [7]
RapamycinExtended lifespan in genetically diverse mice. [9] (preclinical)In a 48-week trial in healthy adults, the main outcome (visceral fat) did not change significantly. [10]No human lifespan data found in the sources checked.
MetforminNot checked in this review.Not checked in this review.In healthy adults 65 and older doing resistance training, metformin blunted gains in lean mass and thigh muscle compared with placebo. [11]
Biological-age testsn/aExperts say clinical use is limited and that tests must be validated at the level of individuals. [12]No evidence that knowing your test number improves health.

NAD+, NMN and nicotinamide riboside

  • A randomized trial in 80 healthy middle-aged adults (60 days of NMN or placebo) found higher blood NAD and longer walking distance in a six-minute test than placebo, and a general health survey score that was better than placebo; a "blood biological age" calculator score rose in the placebo group and stayed unchanged in the NMN groups. Doses of 300, 600 and 900 mg a day were tested (study amounts, not recommendations), and several authors were employees of companies in the field. [2]
  • A randomized trial in 60 older adults (250 mg a day of NMN for 12 weeks) found no significant difference in the primary stepping test, but a shorter 4-meter walking time and better sleep questionnaire scores in the NMN group; the authors were employees of Meiji Holdings. [13]
  • A crossover trial of nicotinamide riboside in middle-aged and older adults found it was well tolerated and raised NAD+; the authors suggested later trials should look at blood pressure and arterial stiffness. [3]
  • In older adults with mild cognitive impairment, a 10-week trial of nicotinamide riboside raised blood NAD+ 2.6-fold, but cognition scores did not change; the authors said a larger, longer trial is needed. The study product was supplied by a company, and one co-author holds related intellectual property. [14]

What this adds up to: NAD+ in the blood can be raised, and the products were well tolerated in these short trials. Promising but limited for walking and sleep in two NMN trials, insufficient evidence that it slows aging or prevents disease. Proper evidence not found among the sources checked for any trial showing that NMN or nicotinamide riboside extends human lifespan or prevents falls, fractures or dementia.

Resveratrol

Resveratrol is a plant compound. In a mouse study, rapamycin extended life but resveratrol and simvastatin did not significantly affect survival. [4] In people, a meta-analysis found improvements in endothelial (blood-vessel lining) markers, a biomarker finding; the authors say it could matter especially for people with cardiovascular disease. [5]

Senolytics, rapamycin and metformin are drugs

Dasatinib, rapamycin and metformin are prescription medicines. The studies above are research, not a basis for self-treatment. In the 60-woman senolytic trial, no serious adverse events were observed, but the primary endpoint did not differ from control. [7] An older-adult rapamycin pilot (25 people) found reductions in several red blood cell measures in the treatment group. [15] The 48-week PEARL trial found adverse events were similar across groups, and its authors are employees and shareholders of the company that ran it. [10] Metformin's effect on muscle in the trial above is a reminder that a drug with an "anti-aging" reputation can have downsides. [11] Proper evidence not found among the sources read for any of these drugs extending healthy lifespan in people.

Biological-age and "anti-aging" tests

Experts in the Biomarkers of Aging Consortium surveyed barriers and said clinical translation remains limited, recommending that biomarkers be linked to clinically actionable insights and validated as robust and responsive in individuals. [12]

Safety and professional care

When to get help

Stop a product and call your provider if you have a reaction, and tell them about everything you take. [16]

Frequently asked questions

Does NMN make you live longer?

In animals, authors report longer lifespan; in people, trials so far raised blood NAD and showed small, short-term changes in some function tests. Proper evidence not found for longer human life. [2] [13]

Is resveratrol an anti-aging supplement?

Not in mice, where it did not significantly change survival; human studies show vessel-lining marker changes, not longer life. [4] [5]

Can a biological-age test tell me how long I will live?

Experts say these tests need more validation before they are clinically useful for individuals. [12]

Is rapamycin or metformin proven to extend healthy life?

Rapamycin extended life in mice. [9] In people, the checked trials were short safety and function studies; metformin blunted muscle gains in older adults doing resistance training. [11]

References

  1. National Institute on Aging. Dietary supplements for older adults. Read 2026-10-22.
  2. Yi L, et al. The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. Geroscience. 2023. Read 2026-10-22.
  3. Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018. Read 2026-10-22.
  4. Miller RA, et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2011. Read 2026-10-22.
  5. Resveratrol supplementation efficiently improves endothelial health: a systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2022. Read 2026-10-22.
  6. Proshkina E, et al. Polyphenols as potential geroprotectors. Antioxid Redox Signal. 2024. Read 2026-10-22.
  7. Farr JN, et al. Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial. Nat Med. 2024. Read 2026-10-22.
  8. Hickson LJ, et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019. Read 2026-10-22.
  9. Harrison DE, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009. Read 2026-10-22.
  10. Moel M, et al. Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results. Aging (Albany NY). 2025. Read 2026-10-22.
  11. Walton RG, et al. Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: a randomized, double-blind, placebo-controlled, multicenter trial. Aging Cell. 2019. Read 2026-10-22.
  12. Biomarkers of Aging Consortium; Herzog CMS, et al. Challenges and recommendations for the translation of biomarkers of aging. Nat Aging. 2024. Read 2026-10-22.
  13. Morifuji M, et al. Ingestion of beta-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study. Geroscience. 2024. Read 2026-10-22.
  14. Orr ME, et al. A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. Geroscience. 2024. Read 2026-10-22.
  15. Kraig E, et al. A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort. Exp Gerontol. 2018. Read 2026-10-22.
  16. National Institute on Aging. Taking medicines safely as you age. Read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.